Multifaceted roles of adiponectin in rheumatoid arthritis.

[1]  Yeon-Ah Lee,et al.  Increased expression of endocan in arthritic synovial tissues: effects of adiponectin on the expression of endocan in fibroblast-like synoviocytes. , 2015, Molecular medicine reports.

[2]  Bo Liu,et al.  Low-molecular-weight adiponectin is more closely associated with disease activity of rheumatoid arthritis than other adiponectin multimeric forms , 2015, Clinical Rheumatology.

[3]  F. Berenbaum,et al.  Response to ‘Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort’ – authors’ reply , 2014, Arthritis Research & Therapy.

[4]  S. Chimenti,et al.  One‐year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate‐to‐severe plaque psoriasis , 2014, The British journal of dermatology.

[5]  Yeon-Ah Lee,et al.  The role of adiponectin in the production of IL-6, IL-8, VEGF and MMPs in human endothelial cells and osteoblasts: implications for arthritic joints , 2013, Experimental & Molecular Medicine.

[6]  L. Klareskog,et al.  Adaptive immunity in rheumatoid arthritis: anticitrulline and other antibodies in the pathogenesis of rheumatoid arthritis , 2014, Current opinion in rheumatology.

[7]  F. Berenbaum,et al.  Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort , 2013, Arthritis Research & Therapy.

[8]  E. Choy,et al.  Enhanced and persistent levels of interleukin (IL)‐17+CD4+ T cells and serum IL‐17 in patients with early inflammatory arthritis , 2013, Clinical and experimental immunology.

[9]  A. Gottlieb,et al.  Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial , 2013, The Lancet.

[10]  K. Yamagishi,et al.  Total and high molecular weight adiponectin levels and risk of cardiovascular disease in individuals with high blood glucose levels. , 2013, Atherosclerosis.

[11]  Jin-jian Lu,et al.  Adiponectin: a biomarker for rheumatoid arthritis? , 2013, Cytokine & growth factor reviews.

[12]  Pavlov Ab,et al.  Detecting adiponectin in industrial workers having inflammatory diseases of joints , 2013 .

[13]  J. Gómez-Reino,et al.  Adiponectin and Leptin Induce VCAM-1 Expression in Human and Murine Chondrocytes , 2012, PloS one.

[14]  K. Hiromura,et al.  Interleukin-6 promotes destabilized angiogenesis by modulating angiopoietin expression in rheumatoid arthritis. , 2012, Rheumatology.

[15]  P. Tak,et al.  Brief report: a phase IIa, randomized, double-blind, placebo-controlled trial of apilimod mesylate, an interleukin-12/interleukin-23 inhibitor, in patients with rheumatoid arthritis. , 2012, Arthritis and rheumatism.

[16]  Yeon-Ah Lee,et al.  Synergy between adiponectin and interleukin-1β on the expression of interleukin-6, interleukin-8, and cyclooxygenase-2 in fibroblast-like synoviocytes , 2012, Experimental & Molecular Medicine.

[17]  Han-Soo Kim,et al.  Adiponectin Induces Dendritic Cell Activation via PLCγ/JNK/NF-κB Pathways, Leading to Th1 and Th17 Polarization , 2012, The Journal of Immunology.

[18]  W. Maśliński,et al.  Comparison of rheumatoid articular adipose and synovial tissue reactivity to proinflammatory stimuli: contribution to adipocytokine network , 2011, Annals of the rheumatic diseases.

[19]  G. Qiu,et al.  Adiponectin receptor 1 mediates the difference in adiponectin- induced prostaglandin E2 production in rheumatoid arthritis and osteoarthritis synovial fibroblasts. , 2011, Chinese medical journal.

[20]  T. Moilanen,et al.  Adiponectin associates with markers of cartilage degradation in osteoarthritis and induces production of proinflammatory and catabolic factors through mitogen-activated protein kinase pathways , 2011, Arthritis research & therapy.

[21]  J. Ortonne,et al.  A 52-week trial comparing briakinumab with methotrexate in patients with psoriasis. , 2011, The New England journal of medicine.

[22]  E. Alkady,et al.  [Serum and synovial adiponectin, resistin, and visfatin levels in rheumatoid arthritis patients. Relation to disease activity]. , 2011, Zeitschrift fur Rheumatologie.

[23]  T. Huizinga,et al.  Baseline serum adipokine levels predict radiographic progression in early rheumatoid arthritis. , 2011, Arthritis and rheumatism.

[24]  J. Gómez-Reino,et al.  What's new in our understanding of the role of adipokines in rheumatic diseases? , 2011, Nature Reviews Rheumatology.

[25]  E. Alkady,et al.  Adiponectin, Resistin und Visfatin in Serum und Gelenkflüssigkeit bei Patienten mit rheumatoider Arthritis , 2011, Zeitschrift für Rheumatologie.

[26]  D. M. van der Heijde,et al.  Association of circulating adiponectin levels with progression of radiographic joint destruction in rheumatoid arthritis , 2011, Annals of the rheumatic diseases.

[27]  Chih-Hsin Tang,et al.  Adiponectin increases MMP‐3 expression in human chondrocytes through adipor1 signaling pathway , 2011, Journal of cellular biochemistry.

[28]  H. Endo,et al.  Elevated serum levels of resistin, leptin, and adiponectin are associated with C-reactive protein and also other clinical conditions in rheumatoid arthritis. , 2011, Internal medicine.

[29]  E. Lee,et al.  Adiponectin is a potential catabolic mediator in osteoarthritis cartilage , 2010, Arthritis research & therapy.

[30]  U. Demkow,et al.  Adiponectin as a biomarker of the metabolic syndrome in children and adolescents , 2010, European journal of medical research.

[31]  C. Buechler,et al.  Adiponectin receptor binding proteins – recent advances in elucidating adiponectin signalling pathways , 2010, FEBS letters.

[32]  U. Müller-Ladner,et al.  Adiponectin-mediated changes in effector cells involved in the pathophysiology of rheumatoid arthritis. , 2010, Arthritis and rheumatism.

[33]  U. Müller-Ladner,et al.  Rheumatoid arthritis progression mediated by activated synovial fibroblasts. , 2010, Trends in molecular medicine.

[34]  Jin Seok Jeong,et al.  Effect of taurine chloramine on the production of matrix metalloproteinases (MMPs) in adiponectin- or IL-1β-stimulated fibroblast-like synoviocytes , 2010, Journal of Biomedical Science.

[35]  A. Işık,et al.  Serum adiponectin and vaspin levels in rheumatoid arthritis. , 2010, Archives of medical research.

[36]  H. Endo,et al.  Adiponectin stimulates prostaglandin E(2) production in rheumatoid arthritis synovial fibroblasts. , 2010, Arthritis and rheumatism.

[37]  Zhang Miaoji.  Change and clinical significance of adiponectin in patients with rheumatoid arthritis , 2010 .

[38]  C. Costa,et al.  TNF, Pig CD86, and VCAM-1 Identified as Potential Targets for Intervention in Xenotransplantation of Pig Chondrocytes , 2009, Cell transplantation.

[39]  D. Hahm,et al.  Adiponectin may contribute to synovitis and joint destruction in rheumatoid arthritis by stimulating vascular endothelial growth factor, matrix metalloproteinase-1, and matrix metalloproteinase-13 expression in fibroblast-like synoviocytes more than proinflammatory mediators , 2009, Arthritis research & therapy.

[40]  W. Scott,et al.  Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis. , 2009, Arthritis and rheumatism.

[41]  S. Gaffen.  Structure and signalling in the IL-17 receptor family , 2009, Nature Reviews Immunology.

[42]  T. Pincus,et al.  Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. , 2009, Arthritis and rheumatism.

[43]  Shaoheng He,et al.  High adiponectin and adiponectin receptor 1 expression in synovial fluids and synovial tissues of patients with rheumatoid arthritis. , 2009, Seminars in arthritis and rheumatism.

[44]  F. Mach,et al.  Update on therapeutic strategies to increase adiponectin function and secretion in metabolic syndrome , 2009, Diabetes, obesity & metabolism.

[45]  M. Netea,et al.  Circulating Leptin and Adiponectin Concentrations During Tumor Necrosis Factor Blockade in Patients with Active Rheumatoid Arthritis , 2009, The Journal of Rheumatology.

[46]  T. Kakiuchi,et al.  Adiponectin stimulates IL-8 production by rheumatoid synovial fibroblasts. , 2009, Biochemical and biophysical research communications.

[47]  Lily Q. Dong,et al.  APPL1: role in adiponectin signaling and beyond. , 2009, American journal of physiology. Endocrinology and metabolism.

[48]  I. Bruce,et al.  Biomarkers of oxidant stress, insulin sensitivity and endothelial activation in rheumatoid arthritis: a cross-sectional study of their association with accelerated atherosclerosis , 2009, BMC Research Notes.

[49]  M. Matsuda,et al.  Serum adiponectin concentrations correlate with severity of rheumatoid arthritis evaluated by extent of joint destruction , 2009, Clinical Rheumatology.

[50]  J. Gómez-Reino,et al.  A new player in cartilage homeostasis: adiponectin induces nitric oxide synthase type II and pro-inflammatory cytokines in chondrocytes. , 2008, Osteoarthritis and cartilage.

[51]  D. Littman,et al.  The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt , 2008, Nature Immunology.

[52]  J. Smolen,et al.  Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial , 2008, The Lancet.

[53]  S. Lee,et al.  Adiponectin mitigates the severity of arthritis in mice with collagen‐induced arthritis , 2008, Scandinavian journal of rheumatology.

[54]  M. Hamdy,et al.  Plasma and synovial fluid adipocytokines in patients with rheumatoid arthritis and osteoarthritis. , 2008, The Egyptian journal of immunology.

[55]  C. Mantzoros,et al.  Leptin and adipocytokines: bridging the gap between immunity and atherosclerosis. , 2007, Current pharmaceutical design.

[56]  A. Batistatou,et al.  Review. Leukocyte and endothelial cell adhesion molecules in inflammation focusing on inflammatory heart disease. , 2007, In vivo.

[57]  M. Feldmann,et al.  Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases. , 2007, Current opinion in pharmacology.

[58]  W. Garvey,et al.  Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease , 2007, Current opinion in lipidology.

[59]  K. Walsh,et al.  Adiponectin as an anti-inflammatory factor. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[60]  I. McInnes,et al.  Emerging cytokine targets in rheumatoid arthritis , 2007, Current opinion in rheumatology.

[61]  C. Behre.  Adiponectin, obesity and atherosclerosis , 2007, Scandinavian journal of clinical and laboratory investigation.

[62]  J. Bełtowski,et al.  Leptin and atherosclerosis. , 2006, Atherosclerosis.

[63]  W. B. van den Berg,et al.  Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis , 2006, Annals of the rheumatic diseases.

[64]  K. Pavelka,et al.  Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis. , 2006, Cytokine.

[65]  R. Ahima.  Adipose Tissue as an Endocrine Organ , 2006, Obesity.

[66]  S. Tsai,et al.  Evidence for a protective role for adiponectin in osteoarthritis. , 2006, Biochimica et biophysica acta.

[67]  Kohjiro Ueki,et al.  Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. , 2006, The Journal of clinical investigation.

[68]  L. Joosten,et al.  Interleukin-17 Acts Independently of TNF-α under Arthritic Conditions1 , 2006, The Journal of Immunology.

[69]  H. Weiner,et al.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.

[70]  H. Ekmekçi,et al.  The Role of Adiponectin in Atherosclerosis and Thrombosis , 2006, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[71]  U. Müller-Ladner,et al.  The Potential of Adiponectin in Driving Arthritis1 , 2006, The Journal of Immunology.

[72]  E. Choy,et al.  Joint inflammation and cytokine inhibition in rheumatoid arthritis , 2006, Clinical and Experimental Medicine.

[73]  J. Gómez-Reino,et al.  Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis , 2006, Annals of the rheumatic diseases.

[74]  W. Garvey,et al.  Adiponectin multimeric complexes and the metabolic syndrome trait cluster. , 2006, Diabetes.

[75]  Ying Wang,et al.  A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 , 2005, Nature Immunology.

[76]  R. D. Hatton,et al.  Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.

[77]  I. McInnes,et al.  Cytokine networks—towards new therapies for rheumatoid arthritis , 2005, Nature Clinical Practice Rheumatology.

[78]  L. Joosten,et al.  Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. , 2005, The American journal of pathology.

[79]  S. Kihara,et al.  Adiponectin Stimulates Angiogenesis in Response to Tissue Ischemia through Stimulation of AMP-activated Protein Kinase Signaling* , 2004, Journal of Biological Chemistry.

[80]  J. Flier,et al.  Adipose Tissue as an Endocrine Organ , 2014 .

[81]  L. Joosten,et al.  Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. , 2004, Arthritis and rheumatism.

[82]  U. Müller-Ladner,et al.  Adipocytokines in synovial fluid. , 2003, JAMA.

[83]  Philippe Froguel,et al.  Cloning of adiponectin receptors that mediate antidiabetic metabolic effects , 2003, Nature.

[84]  J. Engel,et al.  Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/Adiponectin , 2003, The Journal of Biological Chemistry.

[85]  Clifton O Bingham,et al.  The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammation. , 2002, The Journal of rheumatology. Supplement.

[86]  P. Tak,et al.  NF-κB: a key role in inflammatory diseases , 2001 .

[87]  Y. Okada,et al.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis , 2000, Annals of the rheumatic diseases.

[88]  S. Santavirta,et al.  Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis , 1999, Annals of the rheumatic diseases.

[89]  P. Zimmet,et al.  Etiology of the Metabolic Syndrome: Potential Role of Insulin Resistance, Leptin Resistance, and Other Players , 1999, Annals of the New York Academy of Sciences.

[90]  J. von Kempis,et al.  Vascular cell adhesion molecule 1 (CD106) on primary human articular chondrocytes: functional regulation of expression by cytokines and comparison with intercellular adhesion molecule 1 (CD54) and very late activation antigen 2. , 1998, Arthritis and rheumatism.

[91]  S. Ghosh,et al.  Signal transduction through NF-κB , 1998 .

[92]  R. Heller,et al.  Cytokine Control of Interstitial Collagenase and Collagenase-3 Gene Expression in Human Chondrocytes* , 1996, The Journal of Biological Chemistry.

[93]  B. Spiegelman,et al.  AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity (*) , 1996, The Journal of Biological Chemistry.

[94]  T. Funahashi,et al.  cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). , 1996, Biochemical and biophysical research communications.

[95]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .

[96]  Philipp E. Scherer,et al.  A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*) , 1995, The Journal of Biological Chemistry.

[97]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.

[98]  A. Mauviel.  Cytokine regulation of metalloproteinase gene expression , 1993, Journal of cellular biochemistry.

[99]  B. Ranscht,et al.  T-cadherin, a novel cadherin cell adhesion molecule in the nervous system lacks the conserved cytoplasmic region , 1991, Neuron.